Abivax S.A. Increase Decrease In Working Capital
Abivax S.A. (ABVX) reported Increase Decrease In Working Capital of -EUR 3.65 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInWorkingCapital · last filed 2026-03-23
- Abivax S.A. increase decrease in working capital for the quarter ending 2025-12-31 was 9.73M EUR.
- Abivax S.A. increase decrease in working capital for the quarter ending 2025-09-30 was 2.08M EUR.
- Abivax S.A. increase decrease in working capital for the quarter ending 2025-06-30 was -6.45M EUR, a 138.02% decline year-over-year.
- Abivax S.A. increase decrease in working capital for the quarter ending 2025-03-31 was -9.01M EUR.
| Period end | Increase Decrease In Working Capital 3 month | Increase Decrease In Working Capital 6 month | Increase Decrease In Working Capital 9 month | Increase Decrease In Working Capital 12 month |
|---|---|---|---|---|
| 2025-12-31 | 9.73M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-23 | 11.81M EUR derived: sum of 2 quarters · filed 2026-03-23 | 5.36M EUR derived: sum of 3 quarters · filed 2026-03-23 | -3.65M EUR 20-F · filed 2026-03-23 |
| 2025-09-30 | 2.08M EUR derived: 6-K 9 month − 6-K 6 month · filed 2025-12-15 | -4.38M EUR derived: sum of 2 quarters · filed 2025-12-15 | -13.39M EUR 6-K · filed 2025-12-15 | -17.57M EUR derived: sum of 4 quarters · filed 2026-03-23 |
| 2025-06-30 | -6.45M EUR derived: 6-K 6 month − 6-K 3 month · filed 2025-09-08 | -15.46M EUR 6-K · filed 2025-09-08 | -19.64M EUR derived: sum of 3 quarters · filed 2026-03-23 | -29.93M EUR derived: sum of 4 quarters · filed 2026-03-23 |
| 2025-03-31 | -9.01M EUR 6-K · filed 2025-06-02 | -13.20M EUR derived: sum of 2 quarters · filed 2026-03-23 | -23.48M EUR derived: sum of 3 quarters · filed 2026-03-23 | -6.51M EUR derived: sum of 4 quarters · filed 2026-03-23 |
| 2024-12-31 | -4.18M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-23 | -14.47M EUR derived: sum of 2 quarters · filed 2026-03-23 | 2.50M EUR derived: sum of 3 quarters · filed 2026-03-23 | -1.42M EUR 20-F · filed 2026-03-23 |
| 2024-09-30 | -10.28M EUR derived: 6-K 9 month − 6-K 6 month · filed 2025-12-15 | 6.68M EUR derived: sum of 2 quarters · filed 2025-12-15 | 2.76M EUR 6-K · filed 2025-12-15 | |
| 2024-06-30 | 16.97M EUR derived: 6-K 6 month − 6-K 3 month · filed 2025-09-08 | 13.04M EUR 6-K · filed 2025-09-08 | ||
| 2024-03-31 | -3.92M EUR 6-K · filed 2025-06-02 | |||
| 2023-12-31 | -21.27M EUR 20-F · filed 2026-03-23 | |||
| 2022-12-31 | 2.00M EUR 20-F · filed 2025-03-24 | |||
| 2021-12-31 | 667.00K EUR 20-F · filed 2024-04-05 |